SAN LUIS OBISPO, Calif., Nov. 18, 2026 /PRNewswire/ — Fziomed, Inc. (“Fziomed” or the “Company”), a global leader in postsurgical adhesion prevention biomaterials and surgical innovation, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Dynavisc® Tendon Protector. Dynavisc is a fully synthetic, ready-to-use, absorbable gel designed to protect tendons, ligaments, and skeletal muscle following surgical procedures.
Developed using Fziomed’s proprietary dual-polymer technology, Dynavisc is a clear, absorbable gel applied directly to the surgical site following tendon repair. Dynavisc coats exposed tissues, creating a temporary physical barrier that separates and protects adjacent tissues during the healing process, which may aid in reducing postoperative pain, preserving range of motion, and supporting functional recovery.